Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03764878 · ClinicalTrials.gov registry record
MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 15
- Enrollment target
NCT03764878: Completed study, sponsored by Endeavor Health.
NCT03764878 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03764878 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate functional MRI as a tool to study placental transfer of oxygen and nutrients during the third trimester of pregnancy in obese women, women with pregestational diabetes and healthy low risk women without these conditions (controls). The investigators hypothesize that altered placental function, including diminished placental oxygenation and enhanced placental transport of lipids and metabolites will be seen in obese and pregestational diabetics as compared to controls.
Primary Outcome
As measured by the change in MRI from baseline (room air) compared to hyperoxygenation (O2 facemask) in the central area of the placenta
Interventions
- DIAGNOSTIC_TEST functional MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2020-06-01 |
What the finished NCT03764878 record still lists
NCT03764878 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which functional MRI is the first listed.
NCT03764878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03764878 about?
NCT03764878 is a clinical study titled "MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function". The objective of this study is to evaluate functional MRI as a tool to study placental transfer of oxygen and nutrients during the third trimester of pregnancy in obese women, women with pregestational diabetes and healthy low risk women without these conditions (controls). The investigators hypothe...
What is the current status of trial NCT03764878?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-11-29. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03764878?
The interventions under investigation include: functional MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03764878?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI